Andean Precious Metals (CVE:APM) Shares Down 10.4% – Should You Sell?

Andean Precious Metals Corp. (CVE:APM)’s share price fell 10.4% on Tuesday . The stock traded as low as C$1.12 and last traded at C$1.12. 535,049 shares traded hands during trading, an increase of 177% from the average session volume of 193,465 shares. The stock had previously closed at C$1.25.

Wall Street Analysts Forecast Growth

Separately, Desjardins raised shares of Andean Precious Metals to a “moderate buy” rating in a research report on Thursday, October 31st.

Andean Precious Metals Stock Down 8.8 %

The company’s fifty day moving average price is C$1.46 and its two-hundred day moving average price is C$1.25. The company has a market cap of C$170.27 million, a price-to-earnings ratio of 3.00 and a beta of 1.22.

Insiders Place Their Bets

In related news, insider 2176423 Ontario Ltd. acquired 213,800 shares of the business’s stock in a transaction on Wednesday, October 2nd. The stock was purchased at an average cost of C$1.38 per share, for a total transaction of C$294,530.88. Insiders have acquired a total of 306,200 shares of company stock valued at $432,953 over the last 90 days. 69.37% of the stock is currently owned by insiders.

About Andean Precious Metals

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.